Company Filing History:
Years Active: 2023-2025
Title: Innovations by Rajni Verma in Diabetes and Cancer Treatment
Introduction
Rajni Verma is an accomplished inventor based in Wichita, Kansas, known for her significant contributions to the fields of diabetes and cancer treatment. With a total of two patents to her name, she has made remarkable strides in the synthesis of important compounds that hold therapeutic potential.
Latest Patents
Rajni's latest patents include the "Low-temperature synthesis of thymoquinone and harmaline compounds." This innovative work focuses on the low-temperature syntheses of thymoquinone and harmaline compounds, which are useful for the treatment of human diabetes and cancers. The patents also cover the derivatives, solvates, prodrugs, isomers, and tautomers of such compounds. Another notable patent is related to "Harmine synthesis," which describes methods for synthesizing harmine by reacting harmaline with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) in the presence of a diacid catalyst. This synthesis is carried out using a reaction mixture of harmaline, DDQ, THF solvent, and succinic acid, under an inert atmosphere with refluxing for a period of 4-12 hours.
Career Highlights
Rajni Verma is currently associated with Ankh Life Sciences Limited, where she continues to advance her research and development efforts. Her work is pivotal in creating innovative solutions for pressing health issues.
Collaborations
Rajni collaborates with esteemed colleagues such as Gene H Zaid and Krishna Mohan Donavalli, contributing to a dynamic research environment that fosters innovation.
Conclusion
Rajni Verma's contributions to the synthesis of compounds for diabetes and cancer treatment highlight her role as a leading inventor in the field. Her innovative patents and collaborative efforts continue to pave the way for advancements in medical science.